IBDEI2HE ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41638,1,3,0)
 ;;=3^J3303
 ;;^UTILITY(U,$J,358.3,41639,0)
 ;;=J3410^^191^2118^7^^^^1
 ;;^UTILITY(U,$J,358.3,41639,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41639,1,2,0)
 ;;=2^Hydroxyzine HCL up to 25mg
 ;;^UTILITY(U,$J,358.3,41639,1,3,0)
 ;;=3^J3410
 ;;^UTILITY(U,$J,358.3,41640,0)
 ;;=J1094^^191^2118^4^^^^1
 ;;^UTILITY(U,$J,358.3,41640,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41640,1,2,0)
 ;;=2^Dexamethasone, per mg
 ;;^UTILITY(U,$J,358.3,41640,1,3,0)
 ;;=3^J1094
 ;;^UTILITY(U,$J,358.3,41641,0)
 ;;=J3490^^191^2118^1^^^^1
 ;;^UTILITY(U,$J,358.3,41641,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41641,1,2,0)
 ;;=2^Bupivicaine Hcl 1 ml
 ;;^UTILITY(U,$J,358.3,41641,1,3,0)
 ;;=3^J3490
 ;;^UTILITY(U,$J,358.3,41642,0)
 ;;=J3471^^191^2118^8^^^^1
 ;;^UTILITY(U,$J,358.3,41642,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41642,1,2,0)
 ;;=2^Ovine,Up to 999 USP Units
 ;;^UTILITY(U,$J,358.3,41642,1,3,0)
 ;;=3^J3471
 ;;^UTILITY(U,$J,358.3,41643,0)
 ;;=26535^^191^2119^1^^^^1
 ;;^UTILITY(U,$J,358.3,41643,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41643,1,2,0)
 ;;=2^Arthroplasty, interphalangeal joint; each joint
 ;;^UTILITY(U,$J,358.3,41643,1,3,0)
 ;;=3^26535
 ;;^UTILITY(U,$J,358.3,41644,0)
 ;;=26536^^191^2119^2^^^^1
 ;;^UTILITY(U,$J,358.3,41644,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41644,1,2,0)
 ;;=2^Arthroplasty, interphalangeal joint; with prosthetic implant, each jointangeal 
 ;;^UTILITY(U,$J,358.3,41644,1,3,0)
 ;;=3^26536
 ;;^UTILITY(U,$J,358.3,41645,0)
 ;;=27650^^191^2119^15^^^^1
 ;;^UTILITY(U,$J,358.3,41645,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41645,1,2,0)
 ;;=2^Repair, primary, open or percutaneous, ruptured Achilles tendon
 ;;^UTILITY(U,$J,358.3,41645,1,3,0)
 ;;=3^27650
 ;;^UTILITY(U,$J,358.3,41646,0)
 ;;=27686^^191^2119^7^^^^1
 ;;^UTILITY(U,$J,358.3,41646,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41646,1,2,0)
 ;;=2^Lengthening or shortening of tendon each, leg or ankle; multiple  tendon
 ;;^UTILITY(U,$J,358.3,41646,1,3,0)
 ;;=3^27686
 ;;^UTILITY(U,$J,358.3,41647,0)
 ;;=27685^^191^2119^8^^^^1
 ;;^UTILITY(U,$J,358.3,41647,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41647,1,2,0)
 ;;=2^Lengthening or shortening of tendon, leg or ankle; single tendon
 ;;^UTILITY(U,$J,358.3,41647,1,3,0)
 ;;=3^27685
 ;;^UTILITY(U,$J,358.3,41648,0)
 ;;=27695^^191^2119^14^^^^1
 ;;^UTILITY(U,$J,358.3,41648,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41648,1,2,0)
 ;;=2^Repair, primary, disrupted ligament, ankle; both collateral ligaments
 ;;^UTILITY(U,$J,358.3,41648,1,3,0)
 ;;=3^27695
 ;;^UTILITY(U,$J,358.3,41649,0)
 ;;=27698^^191^2119^16^^^^1
 ;;^UTILITY(U,$J,358.3,41649,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41649,1,2,0)
 ;;=2^Repair, secondary, disrupted ligament ankle, collateral
 ;;^UTILITY(U,$J,358.3,41649,1,3,0)
 ;;=3^27698
 ;;^UTILITY(U,$J,358.3,41650,0)
 ;;=28200^^191^2119^19^^^^1
 ;;^UTILITY(U,$J,358.3,41650,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41650,1,2,0)
 ;;=2^Repair, tendon, flexor, foot; primary or secondary, without free graft, each tendon
 ;;^UTILITY(U,$J,358.3,41650,1,3,0)
 ;;=3^28200
 ;;^UTILITY(U,$J,358.3,41651,0)
 ;;=28202^^191^2119^20^^^^1
 ;;^UTILITY(U,$J,358.3,41651,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41651,1,2,0)
 ;;=2^Repair, tendon, flexor, foot; secondarywith free graft, each tendon (includes obtaining graft), 
 ;;^UTILITY(U,$J,358.3,41651,1,3,0)
 ;;=3^28202
 ;;^UTILITY(U,$J,358.3,41652,0)
 ;;=28210^^191^2119^18^^^^1
 ;;^UTILITY(U,$J,358.3,41652,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41652,1,2,0)
 ;;=2^Repair, tendon, extensor, foot; secondary with free graft, each tendon (includes obtaining graft) 
